EUVIMEDEUVIMED entdecken
Crossref

Engineered Platelet‐Derived Growth Factor‐Releasing Hydrogels Promote Fetal Membrane Healing In Vivo

Eva Avilla‐Royo, Ladina Vonzun, Frauke Seehusen, Queralt Vallmajo‐Martin, Flurina Famos, Lukas Moser, Katharina Gegenschatz‐Schmid, Lisa Amanda Krattiger, Nele Strübing, Miriam Weisskopf, Ueli Moehrlen, Nicole Ochsenbein‐Kölble und 1 weitere

Advanced Functional Materials · 2023-02 · 33 (9)

DOI: 10.1002/adfm.202208910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 08.01.2023. Verfasst von Eva Avilla‐Royo und 12 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: UniversitätsSpital Zürich.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fetoscopic interventions to treat fetal anomalies are currently performed for a variety of conditions. Depending on the procedure, preterm rupture of the fetal membranes (FMs) happens in around 30% of the cases, potentially leading to preterm birth and fetal morbidity and mortality. Here, the capacity of modular transglutaminase crosslinked poly(ethylene glycol) (TG‐PEG) hydrogels that release platelet‐derived growth factor (PDGF)‐BB to promote FM healing is described. In vitro, such growth factor‐loaded hydrogels are able to stimulate amniotic cell migration and proliferation. When applied in vivo, these TG‐PEG hydrogels tightly seal the FM and uterus defects created by a fetoscope and remain stable for 10 days. The migration of healing‐related cells into such hydrogels in the myometrium, endometrium, and FM areas is only possible in soft TG‐PEG hydrogels. Importantly, bioengineered hydrogels releasing PDGF‐BB promote recruitment of host cells from the myometrium and the endometrium, and to a lesser extent from FM areas. In such hydrogels, the potent proliferation and matrix production of the recruited cells at the site of treatment into the biomaterial initiates a robust early healing response. PDGF‐BB‐loaded TG‐PEG hydrogels hold great promise for the treatment of fetoscopy‐induced FM defects and for the prevention of preterm birth.

Förderung

  • UniversitätsSpital Zürich

Zitieren

APA

Avilla‐Royo, E., Vonzun, L., Seehusen, F., Vallmajo‐Martin, Q., Famos, F., Moser, L., Gegenschatz‐Schmid, K., Krattiger, L. A., Strübing, N., Weisskopf, M., Moehrlen, U., Ochsenbein‐Kölble, N., & Ehrbar, M. (2023). Engineered Platelet‐Derived Growth Factor‐Releasing Hydrogels Promote Fetal Membrane Healing In Vivo. Advanced Functional Materials, 33(9). https://doi.org/10.1002/adfm.202208910

Vancouver

Avilla‐Royo E, Vonzun L, Seehusen F, Vallmajo‐Martin Q, Famos F, Moser L, et al. Engineered Platelet‐Derived Growth Factor‐Releasing Hydrogels Promote Fetal Membrane Healing In Vivo. Advanced Functional Materials. 2023;33(9). doi:10.1002/adfm.202208910

BibTeX
@article{AvillaRoyo2023,
  author = {Avilla‐Royo, Eva and Vonzun, Ladina and Seehusen, Frauke and Vallmajo‐Martin, Queralt and Famos, Flurina and Moser, Lukas and Gegenschatz‐Schmid, Katharina and Krattiger, Lisa Amanda and Strübing, Nele and Weisskopf, Miriam and Moehrlen, Ueli and Ochsenbein‐Kölble, Nicole and Ehrbar, Martin},
  title = {Engineered Platelet‐Derived Growth Factor‐Releasing Hydrogels Promote Fetal Membrane Healing In Vivo},
  journal = {Advanced Functional Materials},
  year = {2023},
  volume = {33},
  number = {9},
  doi = {10.1002/adfm.202208910}
}
Kostenlos starten →